(VIANEWS) – Business First Bancshares (BFST), Sanmina Corporation (SANM), AMETEK (AME) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Business First Bancshares (BFST)
10.6% sales growth and 10.7% return on equity
Business First Bancshares, Inc. operates as the bank holding company for b1BANK that provides various banking products and services. It offers various deposit products and services, including a range of checking, demand, money market, time, and savings accounts, as well as certificates of deposit; and remote deposit capture and direct deposit services. The company also provides commercial and industrial loans, including commercial lines of credit, working capital loans, term loans, equipment financing, asset acquisition, expansion and development loans, borrowing base loans, letters of credit, and other loan products; construction and development loans; commercial real estate loans; residential real estate loans comprising first and second lien 1-4 family mortgage loans, and home equity lines of credit; and consumer loans, including secured and unsecured installment and term loans. In addition, it offers wealth management products, including mutual funds, annuities, individual retirement accounts, and other financial products. Further, the company provides a range of other financial services comprising drive-through banking facilities, automated teller machines, debit and credit cards, and employee and payroll benefits solutions; and night depository, personalized checks, treasury and cash management, merchant, automated clearing house, electronic funds transfer, domestic and foreign wire transfer, traveler's checks, vault, loan and deposit sweep accounts, lock-box, receivables factoring, correspondent banking, online and mobile banking, e-statements, and bank-by-mail services. The company operates approximately 42 full-service banking centers located in the State of Louisiana and in the Dallas/Fort Worth metroplex. Business First Bancshares, Inc. was incorporated in 2006 and is headquartered in Baton Rouge, Louisiana.
Earnings Per Share
As for profitability, Business First Bancshares has a trailing twelve months EPS of $2.36.
PE Ratio
Business First Bancshares has a trailing twelve months price to earnings ratio of 6.95. Meaning, the purchaser of the share is investing $6.95 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.7%.
Sales Growth
Business First Bancshares’s sales growth is 31.1% for the ongoing quarter and 10.6% for the next.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Feb 13, 2023, the estimated forward annual dividend rate is 0.48 and the estimated forward annual dividend yield is 2.93%.
2. Sanmina Corporation (SANM)
10.5% sales growth and 14.25% return on equity
Sanmina Corporation provides integrated manufacturing solutions, components, products and repair, logistics, and after-market services worldwide. It operates in two businesses, Integrated Manufacturing Solutions; and Components, Products and Services. The company offers product design and engineering, including concept development, detailed design, prototyping, validation, preproduction, manufacturing design release, and product industrialization; assembly and test services; direct order fulfillment and logistics services; after-market product service and support; and supply chain management services, as well as engages in the manufacturing of components, subassemblies, and complete systems. In addition, the company provides interconnect systems, such as printed circuit board fabrication, backplane, cable assemblies, and plastic injection moldings; mechanical systems comprising enclosures and precision machining; memory, storage platforms, radio frequency, optical, and microelectronic solutions; defense and aerospace products; and cloud-based manufacturing execution software. It offers its products and services primarily to original equipment manufacturers in the industrial, medical, defense and aerospace, automotive, communications networks, and cloud solutions industries. Sanmina Corporation was founded in 1980 and is headquartered in San Jose, California.
Earnings Per Share
As for profitability, Sanmina Corporation has a trailing twelve months EPS of $2.81.
PE Ratio
Sanmina Corporation has a trailing twelve months price to earnings ratio of 20.66. Meaning, the purchaser of the share is investing $20.66 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.25%.
Yearly Top and Bottom Value
Sanmina Corporation’s stock is valued at $58.02 at 11:22 EST, way under its 52-week high of $69.28 and way higher than its 52-week low of $36.35.
Revenue Growth
Year-on-year quarterly revenue growth grew by 34.4%, now sitting on 8.49B for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 36% and 19.2%, respectively.
3. AMETEK (AME)
5.3% sales growth and 16.16% return on equity
AMETEK, Inc. manufactures and sells electronic instruments and electromechanical devices in North America, Europe, Asia, and South America. It operates in two segments, Electronic Instruments (EIG) and Electromechanical (EMG). The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; and instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets.Its EMG segment offers engineered electrical connectors and electronics packaging to protect sensitive devices and mission-critical electronics; precision motion control products for data storage, medical devices, business equipment, automation, and other applications; high-purity powdered metals, strips and foils, specialty clad metals, and metal matrix composites; motor-blower systems and heat exchangers for use in thermal management, military, commercial aircraft, and military ground vehicles; and motors for use in commercial appliances, fitness equipment, food and beverage machines, hydraulic pumps, and industrial blowers. This segment also operates a network of aviation maintenance, repair, and overhaul facilities. In addition, the company offers clinical and educational communication solutions. AMETEK, Inc. was incorporated in 1930 and is headquartered in Berwyn, Pennsylvania.
Earnings Per Share
As for profitability, AMETEK has a trailing twelve months EPS of $5.01.
PE Ratio
AMETEK has a trailing twelve months price to earnings ratio of 27.41. Meaning, the purchaser of the share is investing $27.41 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.16%.
Moving Average
AMETEK’s value is below its 50-day moving average of $142.15 and above its 200-day moving average of $129.56.
Sales Growth
AMETEK’s sales growth is 5.5% for the present quarter and 5.3% for the next.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Dec 5, 2022, the estimated forward annual dividend rate is 0.88 and the estimated forward annual dividend yield is 0.61%.
Volume
Today’s last reported volume for AMETEK is 156911 which is 85.03% below its average volume of 1048630.
4. NuVasive (NUVA)
5.3% sales growth and 4.86% return on equity
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. it provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology and its intraoperative neuromonitoring services and support; and specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone. The company also offers reline fixation system that facilitates the preservation and restoration of patient alignment; integrated global alignment platform consisting of Bendini spinal rod bending system that assists with manual rod manipulation for spinal fixation; Lessray that is an image enhancement platform designed to reduce radiation exposure in the operating room, as well as Pulse, which integrates multiple enabling technologies to enhance workflow, reduce variability, and increase the reproducibility of surgical outcomes; and various biologics that are used to aid in the spinal fusion or bone healing process. In addition, it provides MAGEC, a spinal bracing and distraction system, Precice limb lengthening system, and various other products for treating specialized orthopedic procedures; onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries; and cervical artificial disc technology for cervical total disc replacement procedures. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California.
Earnings Per Share
As for profitability, NuVasive has a trailing twelve months EPS of $0.77.
PE Ratio
NuVasive has a trailing twelve months price to earnings ratio of 54.9. Meaning, the purchaser of the share is investing $54.9 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.86%.
Yearly Top and Bottom Value
NuVasive’s stock is valued at $42.27 at 11:22 EST, way below its 52-week high of $60.47 and way higher than its 52-week low of $35.17.
